AM
Aditya Mahendrabhai Sadaria
About Aditya Mahendrabhai Sadaria
Data last updated:
Aditya Mahendrabhai Sadaria is a Director at Rethink Pharma Private Limited (since 2023). The companies operate in Pharma. Earlier, Aditya Mahendrabhai Sadaria was a Director at Infocus Remedies Private Limited (2018–2026).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 26 Jul 2023 | 2023 | Under Process Of Striking Off |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 06 Apr 2018 | 2018 | ₹1.69 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Aditya Mahendrabhai Sadaria
| Name | DIN | Company | Designation |
|---|---|---|---|
| Akash Sadaria Mahendra | 03579771 | Rethink Pharma Private Limited | Director |
| Karen Du Toit | 07395808 | Rethink Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Aditya Mahendrabhai Sadaria
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aditya Mahendrabhai Sadaria
Aditya Mahendrabhai Sadaria currently holds 1 directorship: Rethink Pharma Private Limited (Director, since 26 Jul 2023).
Aditya Mahendrabhai Sadaria was first appointed on 06 Apr 2018 as Director at Infocus Remedies Private Limited. The most recent appointment on record is 26 Jul 2023 at Rethink Pharma Private Limited.
Aditya Mahendrabhai Sadaria held 1 earlier board appointment: Infocus Remedies Private Limited (Director, 06 Apr 2018 to 17 Jan 2026).
The current boards of Aditya Mahendrabhai Sadaria's companies include Akash Sadaria Mahendra (Rethink Pharma Private Limited), Karen Du Toit (Rethink Pharma Private Limited).